FDA.reportPublic FDA data

Nupharmisto 4% Lidocaine Numbing cream-206

Manufacturer
EveryMarket Inc
Effective date
2026-07-08
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
daily-update
Hydrated at
2026-07-31 05:10:09

Label at a glance#

ProductNupharmisto 4% Lidocaine Numbing cream
Active ingredientLIDOCAINE
Label structure9 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Lidocaine 4%

OTC - PURPOSE SECTION

Local Anesthetic

DOSAGE & ADMINISTRATION SECTION

For the temporary relief of pain and itchin associated with minor burns, sunburn, minor cuts, scrapes, and insect bites.

WARNINGS SECTION

For external use only

Stop and ask a doctor if

  • an llergic reaction occurs.
  • symptom does not improve or if redness, irritation, swelling, pain or other symptoms develop or increase.

OTC - WHEN USING SECTION

do not exceed the recommended daily dosage unless directed by a doctor. Avoid contact with the eyes. Do not use if you are allergic to the ingredients in this product or if the seal is broken or missing.

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of accidental ingestion, seek medical advice immediately or contact a Poison Control Center right away.

INDICATIONS & USAGE SECTION

  • For children under 12, consult a doctor.
  • For adults: If possible, clean the affected area with mild soap and warm water, making sure to rinse thoroughly. Gently dry the area with toilet tissue or a soft cloth before applying the product.
  • Apply up to 4 times daily.

OTHER SAFETY INFORMATION

Store room temperature 59°-86°F(15°-30°C). Keep away from direct sunlight or heat.

INACTIVE INGREDIENT SECTION

DI Water, Dimethyl Isosorbide,Ethylhexyl Palmitate,Hydrogenated Polydecene,Propylene Glycol, Arnica Montana Flower Extract,Helianthus Annuus (Sunflower)Seed Oil, Emu Oil, Menthol,Phenoxyethanol, Sodium Polyacrylate, Trideceth-6,Menthol, Acrylates/C10-30 AlkylAcrylate Crosspolymer,Allantoin, Tocopheryl Acetate,Ethylhexylglycerin, Tetrasodium EDTA.

OTC - QUESTIONS SECTION

Contact us at service@nupharmisto.com

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

packagepackage

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 19 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
85833-00785833-007-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 17 matching rows.

Name, UNII, Kind table
NameUNIIKind
HELIANTHUS ANNUUS (SUNFLOWER) SEED OIL3W1JG795YIIACT
TETRASODIUM EDTAMP1J8420LUIACT
ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER (60000 MPA.S)8Z5ZAL5H3VIACT
ARNICA MONTANA FLOWER WATERU7L2JP51PRIACT
MENTHOLL7T10EIP3AIACT
ETHYLHEXYLGLYCERIN147D247K3PIACT
ETHYLHEXYL PALMITATE2865993309IACT
WATER059QF0KO0RIACT
TRIDECETH-63T5PCR2H0CIACT
HYDROGENATED POLYDECENE (1500 CST)4YI0729529IACT
ALLANTOIN344S277G0ZIACT
ALPHA-TOCOPHEROL ACETATE9E8X80D2L0IACT
EMU OIL344821WD61IACT
DIMETHYL ISOSORBIDESA6A6V432SIACT
LIDOCAINE98PI200987ACTIB
PROPYLENE GLYCOL6DC9Q167V3IACT
PHENOXYETHANOLHIE492ZZ3TIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Nupharmisto 4% Lidocaine Numbing creamLIDOCAINE 4%EveryMarket Inc5615e49d-e03b-f915-e063-6294a90a17862026-07-08WarningsExact identifier
ndc (package): 85833-007-01
ndc (product): 85833-007
ndc11 (package): 85833000701
spl id: 5615e49d-e03c-f915-e063-6294a90a1786
spl set id: 5615e49d-e03b-f915-e063-6294a90a1786

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.